This inventor holds 30 USPTO granted patents and 23 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Arbor Pharmaceuticals, LLC, Xenoport, Inc., Xwpharma Ltd.. Active years: 2013-2025.
Location History:
- Cupertino, CA (US) (2013 - 2024)
- South San Francisco, CA (US) (2024)
Company Filing History:
9 out of 20 
9 out of 142 
8 out of 29 
Years Active: 2013-2025
Areas of Expertise:
Title: **Inventor Spotlight: Sami Karaborni**
Introduction
Sami Karaborni is an innovative inventor based in Cupertino, California, known for his significant contributions to the pharmaceutical industry. With a remarkable portfolio of 25 patents, Karaborni's work reflects his commitment to advancing healthcare solutions through groundbreaking technologies and compositions.
Latest Patents
Among his latest innovations, Karaborni has developed pharmaceutical compositions of dimethyl fumarate. This patent focuses on dosage forms containing low levels of certain impurities, aiming to enhance the efficacy and safety of this medication. Another noteworthy patent involves modified release compositions of a GAMMA-hydroxybutyric acid derivative. This technology includes pharmaceutical granulations with a functional coating designed to provide immediate or modified release of 4-((L-valyl)oxy)butanoic acid, which can be utilized in oral pharmaceutical compositions.
Career Highlights
Sami Karaborni has garnered extensive experience working with reputed companies. He has held positions at Xenoport, Inc., where he contributed to innovative drug delivery systems, and Arbor Pharmaceuticals, LLC, focusing on developing pharmaceutical products that improve patient outcomes. His technical expertise and strategic vision have positioned him as a key player in the pharmaceutical innovation landscape.
Collaborations
Throughout his career, Karaborni has partnered with several esteemed professionals, including coworkers Chen Mao and Wei Chen. These collaborations have been instrumental in driving forward the research and development of his patented inventions, fostering an environment of creativity and progress in the pharmaceutical sector.
Conclusion
Sami Karaborni stands out as a prominent inventor whose work is shaping the future of pharmaceuticals. His numerous patents and collaborative efforts underscore his dedication to developing advanced therapeutic solutions. As the industry continues to evolve, Karaborni's contributions will undeniably play a significant role in improving healthcare worldwide.